By
Drug Target Review2024-03-07T12:00:20
Researchers have developed an algorithm which could improve diagnostics of ovarian high-grade serous carcinoma.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2023-09-27T13:56:39
Sponsored by Euretos
2026-06-24T13:00:00 2026-06-24T14:00:00
Sponsored by HUB Organoids
2023-12-11T10:49:07
Sponsored by Leica Microsystems
2024-01-10T08:56:17
Sponsored by Leica Microsystems
2026-03-11T14:00:00
Sponsored by Merck
2025-04-02T14:00:00
Sponsored by Eurofins Discovery
Site powered by Webvision Cloud